Risk of kidney disease doubled with use of fluoroquinolone antibiotics
The risk of acute kidney disease is doubled for people taking oral fluoroquinolone antibiotics, according to a study of published in CMAJ (Canadian Medical Association Journal).
Fluoroquinolones, including ciprofloxacin, levofloxacin and moxifloxacin, are common broad-spectrum antibiotics most often used to treat respiratory and urogenital infections. Case reports have indicated acute kidney injury with use, and prescription labels carry a warning of kidney failure. However, when oral fluoroquinolones are prescribed in clinical practice, kidney injury is usually not considered.
Researchers from the US and Canada undertook a study to determine the risk of acute kidney injury with the use of oral fluoroquinolones for adult men 40
More information: www.cmaj.ca/lookup/doi/10.1503/cmaj.121730
Journal information: Canadian Medical Association Journal
Provided by Canadian Medical Association Journal